The oncogenic pathways involved in Ph‐like ALL predominantly comprise the ABL‐class, CRLF2, and JAK‐STAT signaling, which are associated with pro‐proliferative or anti‐apoptotic properties and are part of the current risk classification.5, 6. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.